Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Diseases | 2 | 2019 | 179 | 0.540 |
Why?
|
| Genetic Therapy | 2 | 2016 | 720 | 0.520 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2024 | 226 | 0.500 |
Why?
|
| Macular Degeneration | 1 | 2016 | 127 | 0.430 |
Why?
|
| Diabetic Retinopathy | 2 | 2024 | 168 | 0.350 |
Why?
|
| Corneal Neovascularization | 1 | 2006 | 13 | 0.240 |
Why?
|
| Retinal Neovascularization | 1 | 2006 | 18 | 0.240 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 347 | 0.210 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 99 | 0.210 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2023 | 145 | 0.190 |
Why?
|
| Glaucoma | 1 | 2021 | 79 | 0.170 |
Why?
|
| Antibodies, Neutralizing | 1 | 2024 | 500 | 0.170 |
Why?
|
| Cataract | 1 | 2021 | 168 | 0.160 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2019 | 54 | 0.140 |
Why?
|
| Endophthalmitis | 1 | 2018 | 68 | 0.140 |
Why?
|
| Genetic Vectors | 2 | 2016 | 927 | 0.140 |
Why?
|
| Eye Infections, Bacterial | 1 | 2018 | 86 | 0.140 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2018 | 128 | 0.130 |
Why?
|
| Zika Virus | 1 | 2019 | 151 | 0.130 |
Why?
|
| Cataract Extraction | 1 | 2018 | 152 | 0.130 |
Why?
|
| Zika Virus Infection | 1 | 2019 | 175 | 0.130 |
Why?
|
| Choroidal Neovascularization | 1 | 2015 | 34 | 0.110 |
Why?
|
| Bevacizumab | 1 | 2015 | 80 | 0.110 |
Why?
|
| Placenta | 1 | 2019 | 539 | 0.110 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 496 | 0.100 |
Why?
|
| Milk, Human | 1 | 2015 | 308 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1161 | 0.090 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1990 | 35 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 1192 | 0.080 |
Why?
|
| Animals | 6 | 2024 | 34850 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 826 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1990 | 246 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2552 | 0.060 |
Why?
|
| Rats, Inbred BN | 1 | 2006 | 16 | 0.060 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2006 | 36 | 0.060 |
Why?
|
| Macaca fascicularis | 1 | 2006 | 88 | 0.060 |
Why?
|
| Choroid | 1 | 2006 | 36 | 0.060 |
Why?
|
| Iris | 1 | 2006 | 43 | 0.060 |
Why?
|
| Electroretinography | 1 | 2006 | 121 | 0.060 |
Why?
|
| Fluorescein Angiography | 1 | 2006 | 152 | 0.060 |
Why?
|
| Rabbits | 1 | 2006 | 673 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 395 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 1285 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 1224 | 0.050 |
Why?
|
| Retinal Vessels | 1 | 2023 | 78 | 0.050 |
Why?
|
| HIV-1 | 1 | 2006 | 484 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2006 | 862 | 0.050 |
Why?
|
| Gene Expression | 1 | 2006 | 1563 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2021 | 128 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 890 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 623 | 0.040 |
Why?
|
| Humans | 8 | 2024 | 132247 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2021 | 506 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 559 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 608 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 526 | 0.040 |
Why?
|
| Retina | 1 | 2023 | 491 | 0.040 |
Why?
|
| Rats | 1 | 2006 | 3607 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2019 | 111 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2024 | 2511 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2019 | 253 | 0.030 |
Why?
|
| Mice | 2 | 2024 | 18507 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 1175 | 0.030 |
Why?
|
| Microcephaly | 1 | 2019 | 354 | 0.030 |
Why?
|
| Blood-Retinal Barrier | 1 | 2015 | 3 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 576 | 0.030 |
Why?
|
| Phenotype | 2 | 2019 | 4540 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 1718 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 4690 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 4758 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2015 | 154 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2015 | 233 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 1080 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 1009 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 444 | 0.020 |
Why?
|
| Male | 4 | 2019 | 65012 | 0.020 |
Why?
|
| Thioguanine | 1 | 1990 | 22 | 0.020 |
Why?
|
| RNA, Antisense | 1 | 1990 | 36 | 0.020 |
Why?
|
| Gentamicins | 1 | 1990 | 87 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1990 | 77 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1990 | 252 | 0.020 |
Why?
|
| Introns | 1 | 1990 | 305 | 0.020 |
Why?
|
| Plasmids | 1 | 1990 | 459 | 0.020 |
Why?
|
| Mutagenesis | 1 | 1990 | 347 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1990 | 247 | 0.020 |
Why?
|
| Glycols | 1 | 1988 | 6 | 0.020 |
Why?
|
| Self Mutilation | 1 | 1988 | 5 | 0.020 |
Why?
|
| Lesch-Nyhan Syndrome | 1 | 1988 | 11 | 0.020 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 1988 | 35 | 0.020 |
Why?
|
| Homovanillic Acid | 1 | 1988 | 28 | 0.020 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1988 | 30 | 0.020 |
Why?
|
| Transfection | 1 | 1990 | 996 | 0.020 |
Why?
|
| Exons | 1 | 1990 | 806 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1990 | 656 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3853 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3194 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 31614 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3139 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 7557 | 0.020 |
Why?
|
| Base Sequence | 1 | 1990 | 2900 | 0.020 |
Why?
|
| Movement Disorders | 1 | 1988 | 223 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1990 | 3771 | 0.010 |
Why?
|
| Cell Line | 1 | 1990 | 2724 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 9966 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1990 | 2680 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 20557 | 0.010 |
Why?
|
| Female | 2 | 2019 | 70785 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 21482 | 0.010 |
Why?
|
| Fluphenazine | 1 | 1988 | 5 | 0.000 |
Why?
|
| Carbidopa | 1 | 1988 | 17 | 0.000 |
Why?
|
| Catecholamines | 1 | 1988 | 52 | 0.000 |
Why?
|
| Tetrabenazine | 1 | 1988 | 41 | 0.000 |
Why?
|
| Levodopa | 1 | 1988 | 94 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1988 | 14736 | 0.000 |
Why?
|
| Child | 1 | 1988 | 25783 | 0.000 |
Why?
|